Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
ConditionInterstitial Lung Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Eligibility criteria
Qualifiers
Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia
Patients willing to provide written informed consent
Disqualifiers
Unwillingness/unable to give blood samples
Trial design
Treatments tested in this trial
- ILD
- Healthy
- Pneumonia
Treatment groups
635 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov